Seeing Is Believing
with an average price target of $3.08. This is a potential upside of $3.08 (0%) from yesterday's end of day stock price of $0.
Kindred Biosciences's activity chart (see below) currently has 39 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50.3% with an average time for these price targets to be met of 183 days.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 22-Aug-2021. First documented stock forecast 16-Nov-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$15.25
4 years 2 months 3 days ago
(22-Aug-2021)
2/4 (50%)
$10.95 (254.65%)
332
Hold
4 years 4 months 9 days ago
(16-Jun-2021)
2/4 (50%)
$4.96 (35.33%)
30
Hold
$9.25
$11
4 years 4 months 10 days ago
(15-Jun-2021)
1/5 (20%)
$0.02 (0.22%)
69
Hold
$9.25
4 years 4 months 10 days ago
(15-Jun-2021)
1/2 (50%)
$0.02 (0.22%)
69
Buy
$9
$-0.25 (-2.70%)
$13
4 years 5 months 14 days ago
(11-May-2021)
1/3 (33.33%)
$4.7 (109.30%)
35
What is KIN (Kindred Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?
Which analyst has the most public recommendations on KIN (Kindred Biosciences)?
Which analyst is the currently most bullish on KIN (Kindred Biosciences)?
Which analyst is the currently most reserved on KIN (Kindred Biosciences)?